(lp0
S'Keep An Eye On Rexahn Pharmaceuticals Inc  This Year Insider Financial - Mar 13, 2017 Rexahn Pharmaceuticals, Inc.  ran up towards the end of last week on basically no news, and is running again early session in the US on Monday.The Epic Rise of Rexahn Pharmaceuticals, Inc.  - The Oracle DispatchWhy to Keeping Eye on JC Penney Company, Inc. , Rexahn Pharmaceuticals ... - StockNewsJournal'
p1
aS"Rexahn Pharmaceuticals, Inc. : What's the Story? StockNewsJournal - 12 hours ago Rexahn Pharmaceuticals, Inc.  is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $0.42, down from yesterday's close by -8.98%.Rexahn Pharmaceuticals, Inc. subtracted -8.98% in its Stock Price in the ... - Free ObserverRexahn Pharmaceuticals, Inc.  And The Naked Truth Exposed In Its Technicals - NY Stock News"
p2
aS'Rexahn Pharmaceuticals  Jumps: Stock Moves Up 5.4% March 16, 2017 Zacks.com - Mar 16, 2017 Rexahn Pharmaceuticals, Inc.  was a big mover last session, as its shares rose above 5% on the day.'
p3
aS"The Technical Facts on Rexahn Pharmaceuticals, Inc.  The USA Commerce - 13 hours ago We have gathered the technical data on Rexahn Pharmaceuticals, Inc. , and see some interesting trends in the stock's behavior of late."
p4
aS"Rexahn Pharmaceuticals, Inc.  Announces Full Year 2016 Financial Results Smarter Analyst - Feb 27, 2017 Rexahn Pharmaceuticals, Inc.  announced financial results for the year ended December 31, 2016 and provided an update on the Company's clinical development programs.Shares of Rexahn Pharmaceuticals, Inc.  Plunge -4.8% - Energy IndexWhich insiders are trading Rexahn Pharmaceuticals, Inc. ? - Post Analyst"
p5
aS'Rexahn Pharmaceuticals, Inc.  Initiates Clinical Trial to Evaluate the ... Smarter Analyst - Feb 23, 2017 Rexahn Pharmaceuticals, Inc.  announced that is has begun enrolling patients into a Phase IIa clinical study of Supinoxin in metastatic triple negative breast cancer .'
p6
aS"Analyst's Indicator Review for Rexahn Pharmaceuticals, Inc. , The ... The USA Commerce - Mar 21, 2017 Presently Rexahn Pharmaceuticals, Inc.  stock have an ABR of 1.00. This is built on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell."
p7
aS'Rexahn Pharmaceuticals, Inc.  sitting close to a major resistance line on ... USA Commerce Daily - 12 hours ago With all other things going on, Rexahn Pharmaceuticals, Inc.  has been on a run - rising 181.2 percent in just three months.'
p8
aS"What are Analyst's Indicators for Catabasis Pharmaceuticals, Inc. (CATB ... The USA Commerce - Mar 13, 2017 Shares of Catabasis Pharmaceuticals, Inc.  surged 53.38% to $2.04. During the trading on 03/10/2017, Company's stock ranged from $1.58 to $2.76. The relative strength index or RSI highlights overbought  and oversold (below&nbsp;...Biotech Stocks Worth a Closer Look: Catabasis Pharmaceuticals, Inc. (NASDAQ ... - The Voice RegistrarBiotech Stocks Worth Chasing: Catabasis Pharmaceuticals, Inc. , Rexahn ... - The Independent Republic"
p9
aS'In Good Financial Health?  Rexahn Pharmaceuticals, Inc. , The Medicines ... USA Commerce Daily - 19 hours ago Shares of Rexahn Pharmaceuticals, Inc.  are making a strong comeback as they have jumped 262.2% since bottoming out at $0.13 on Dec. 30, 2016.'
p10
a.